Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

ALNY

Alnylam Pharmaceuticals Inc

280.00

Jul 15 • 01:12PM ET -1.26 (-0.45%)

Healthcare Biotechnology USA Large NASD

Peers: ARGX REGN VRTX AMGN GILD BIIB BMRN ONC ABBV LLY

| Held by: VTI VO QQQ VUG VXF VOT IBB IWP CGGR QQQM

Scroll to Statements

Index	NDX
Market Cap	37.38B
Enterprise Value	37.34B
Income	577.22M
Sales	4.29B
Book/sh	8.06
Cash/sh	22.54
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2500
IPO	May 28, 2004

P/E	66.53
Forward P/E	26.49
PEG	0.33
P/S	8.72
P/B	34.75
P/C	12.42
P/FCF	58.29
EV/EBITDA	46.28
EV/Sales	8.71
Quick Ratio	3.06
Current Ratio	3.13
Debt/Eq	2.76
LT Debt/Eq	2.51
Option/Short	Yes / Yes

EPS (ttm)	4.21
EPS next Y	10.57
EPS next Q	1.60
EPS this Y	217.87%
EPS next Y	42.69%
EPS next 5Y	80.15%
EPS past 3/5Y	- -
Sales past 3/5Y	52.98% 49.77%
EPS Y/Y TTM	308.45%
Sales Y/Y TTM	82.57%
EPS Q/Q	440.32%
Sales Q/Q	96.43%
Earnings	Apr 30 BMO
EPS/Sales Surpr.	73.26% 4.63%

Insider Own	0.43%
Insider Trans	-9.58%
Inst Own	98.85%
Inst Trans	-0.12%
ROA	12.36%
ROE	96.94%
ROIC	15.30%
Gross Margin	80.83%
Oper. Margin	17.54%
Profit Margin	13.46%
SMA20	-5.47%
SMA50	-5.17%
SMA200	-22.40%
Trades

Shs Outstand	133.44M
Shs Float	132.94M
Short Float	4.36%
Short Ratio	4.61
Short Interest	5.80M
52W High	495.55 -43.50%
52W Low	273.11 2.52%
Volatility	8.84% 4.63%
ATR (14)	14.46
RSI (14)	38.51
Beta	0.27
Rel Volume	0.46
Avg Volume	1.26M
Volume	341,323

Perf Week	-13.45%
Perf Month	-1.01%
Perf Quarter	-17.50%
Perf Half Y	-24.51%
Perf YTD	-29.59%
Perf Year	-10.00%
Perf 3Y	42.06%
Perf 5Y	62.84%
Perf 10Y	334.24%
Recom	1.67
Target Price	440.78
Prev Close	281.26
Price	280.00
Change	-0.45%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)